Jun. 15 at 12:48 PM
$GNPX Quick update for anyone following the latest.
Genprex has received a Nasdaq delisting notice because the stock closed below
$1 for 30 consecutive business days.
Because the company already completed a reverse split in October 2025, it does not get the normal 180 day compliance period.
Important part this does NOT mean instant delisting. Genprex said it intends to request a Nasdaq hearing, and that request should stay any suspension/delisting action while the hearing process plays out.
So the next key date is now June 18, the annual meeting / proxy vote, where the reverse split proposal becomes even more important.
Not great news, obviously. But also not “game over today.”
The company still has runway into H2 2027, and pipeline milestones are still expected this year.
Now it’s simple management needs to execute and protect shareholders.
NFA
